Showing 1 - 4 results of 4 for search 'Zhiting Zhao', query time: 0.02s Refine Results
  1. 1
    A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy

    A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy by Ranpu Wu, Shaorong Yu, Jinjun Ye, Yimin Wang, Zhiting Zhao, Hongbing Liu, Hongbing Liu, Yong Song, Yong Song

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis

    Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis by Luqing Zhao, Zhiting Zhao, Xiaoqi Yan, Fei Wu, Ning Sun, Renhong Guo, Shaorong Yu, Xiao Hu, Jifeng Feng

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis

    Comparison of Efficacy and Safety of Second-Line Treatment Options for Advanced Small-Cell Lung Cancer: A Retrospective Analysis by Luqing Zhao BS, Zhiting Zhao MM, Xiaoqi Yan BS, Xiao Hu MM, Jifeng Feng MD, Shaorong Yu MD

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study

    Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study by Zhiting Zhao, Luqing Zhao, Guohao Xia, Jianwei Lu, Jianwei Lu, Bo Shen, Guoren Zhou, Fenglei Wu, Xiao Hu, Jifeng Feng, Shaorong Yu, Shaorong Yu

    Published 2023-01-01
    Get full text
    Article

Search Tools: